All In MedTech

Device Trial Radar · NCT02504424

AirXpanders AeroForm Tissue Expander System for Breast Reconstruction

AirXpanders AeroForm Tissue Expander System for Breast Reconstruction (XPAND-II)

Last checked: Nov 20, 2026Latest source record: Jan 29, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

50

Actual

Start

Nov 12, 2015

Primary completion

May 3, 2017

Study completion Sep 26, 2017

Sponsor

Lead sponsor
AirXpanders, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Jul 22, 2015

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
Female only, from 18 years, up to 70 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study is designed to allow existing investigators continued access to the AeroForm Tissue Expander to treat patients while AirXpanders completes a marketing application and during the review process by FDA.

Conditions

  • Breast Cancer

Interventions

  • AeroForm Tissue ExpanderDevice

    The AeroForm Tissue Expander is a breast tissue expander implanted following mastectomy and activated by remote control to release small doses of carbon dioxide from an internal reservoir to fill and inflate the expander.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Breasts With Successful Tissue Expansion With Exchange to a Permanent Breast Implant Unless Exchange is Precluded by a Non-device Related EventTime frame: 6 months

Locations

8 sites in 1 country. Site status is shown where the registry gives one.

  • Marin General Hospital

    Greenbrae, California

  • Good Samaritan Hospital, San Jose

    San Jose, California

  • Broward Health Medical Center

    Fort Lauderdale, Florida

5 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.